Stories

Fiscal Year 2016 achievements in technology transfer, business development

Fiscal Year 2016 achievements in technology transfer, business development

October 13, 2016
For 11 years, TTBD has hosted an award ceremony to celebrate university accomplishments and recognize OHSU employees who’ve made significant contributions to innovation, entrepreneurship, industry partnership, patenting, and technology commercialization. Following are highlights from last night’s 2016 TTBD Awards Ceremony.
Doernbecher researchers awarded more than $9 million to fight Fanconi anemia

Doernbecher researchers awarded more than $9 million to fight Fanconi anemia

By Tracy Brawley October 10, 2016
Thanks to a $9.9 million grant from the National Heart, Lung, and Blood Institute, a team led by Markus Grompe, M.D., director of the Oregon Stem Cell Center at OHSU and the Papé Family Pediatric Research Institute at OHSU Doernbecher Children’s Hospital, will work to understand human response to novel drug treatments that have shown promise in FA-positive animal models.
Targeted drug tames atopic eczema in Phase III trials

Targeted drug tames atopic eczema in Phase III trials

October 03, 2016
A drug that blocks the chemical messengers that are overactive in allergic reactions proved effective in clearing or reducing symptoms caused by atopic eczema, based on results from an international Phase III clinical trial led by OHSU in Portland, Oregon.
New study raises possibility of treating disease through amniotic fluid

New study raises possibility of treating disease through amniotic fluid

By Erik Robinson September 30, 2016
A breakthrough study published online this week in the journal Nucleic Acids Research suggests that it may be possible to treat genetic disease detected in the womb by safely and efficiently delivering gene-altering therapies through a kind of reverse amniocentesis.
See more stories